These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19593850)

  • 1. Prostate-cancer screening.
    Preston SH
    N Engl J Med; 2009 Jul; 361(2):202-3; author reply 204-6. PubMed ID: 19593850
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostate cancer screening: no proof of the benefit].
    Laplanche A; Hill C
    Presse Med; 2009 Oct; 38(10):1393-5. PubMed ID: 19647979
    [No Abstract]   [Full Text] [Related]  

  • 3. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
    Prasad SM; Drazer MW; Huo D; Hu JC; Eggener SE
    JAMA; 2012 Apr; 307(16):1692-4. PubMed ID: 22535850
    [No Abstract]   [Full Text] [Related]  

  • 4. Rural residence and prostate cancer screening with prostate-specific antigen.
    Stamatiou K; Skolarikos A
    Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-cancer screening.
    Catalona WJ
    N Engl J Med; 2009 Jul; 361(2):202; author reply 204-5. PubMed ID: 19587348
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy vs effectiveness in prostate-specific antigen screening.
    Albertsen PC
    J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate-specific antigen: a new(ish) study.
    Harv Mens Health Watch; 2010 Nov; 15(4):6-8. PubMed ID: 21166115
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate-specific antigen testing: good or bad?
    Albertsen PC
    Oncologist; 2015 Mar; 20(3):233-5. PubMed ID: 25673105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-cancer screening.
    Ojha RP; Thertulien R; Fischbach LA
    N Engl J Med; 2009 Jul; 361(2):203; author reply 204-5. PubMed ID: 19593851
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical practice. Screening for prostate cancer.
    Hoffman RM
    N Engl J Med; 2011 Nov; 365(21):2013-9. PubMed ID: 22029754
    [No Abstract]   [Full Text] [Related]  

  • 11. Regular PSA screens undervalued, underutilized in prostate cancer detection.
    Healthc Demand Dis Manag; 2000 May; 6(5):70-2, 65. PubMed ID: 11383016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the manner in which information about prostate-specific antigen (PSA) testing is presented affect screening rates?
    Lockman AR
    J Fam Pract; 2001 Oct; 50(10):898. PubMed ID: 11674897
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of prostate specific antigen screening in the United States: extrapolating from the European study of screening for prostate cancer.
    Shteynshlyuger A; Andriole GL
    J Urol; 2011 Mar; 185(3):828-32. PubMed ID: 21239021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bad habits may be hard to break.
    Vemana G; Andriole GL
    Eur Urol; 2013 Mar; 63(3):426-7. PubMed ID: 23206853
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence-based uncertainty: recent trial results on prostate-specific antigen testing and prostate cancer mortality.
    Smith DP; Banks E; Clements MS; Gardiner RA; Armstrong BK
    Med J Aust; 2009 Aug; 191(4):199-200. PubMed ID: 19705979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of prostate cancer: yes or no?].
    Van Cangh PJ
    Bull Mem Acad R Med Belg; 2006; 161(3-4):159-69. PubMed ID: 17172224
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for prostate cancer: evidence and perspectives.
    Schröder FH; Wildhagen MF;
    BJU Int; 2001 Nov; 88(8):811-7. PubMed ID: 11736853
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer options expand beyond the PSA.
    Clin Resour Manag; 2002 May; 3(5):65-8. PubMed ID: 12048767
    [No Abstract]   [Full Text] [Related]  

  • 19. New trial data do not end the PSA screening debate.
    Vastag B
    J Natl Cancer Inst; 2009 Jun; 101(12):844-5. PubMed ID: 19509364
    [No Abstract]   [Full Text] [Related]  

  • 20. [In depth analysis of 2 studies of prostate cancer screening--what makes sense?].
    Recker F
    Praxis (Bern 1994); 2010 Feb; 99(3):183-5. PubMed ID: 20127638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.